[Study of the spatial structure of des-Gly9-[Arg8]vasopressin by two-dimensional NMR spectroscopy and theoretical conformation analysis]. 1985

M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich

2D 1H-NMR spectra of des-Gly9-[Arg8]vasopressin in dimethylsulfoxide have been taken and the 1H resonances have been assigned. The coupling constants and amide proton temperature coefficients (delta delta/delta T) have been measured and the NOE cross-peaks in the NOESY spectrum have been analyzed. The most essential information on the spatial structure of des-Gly9-[Arg8]vasopressin is extracted from the low delta delta/delta T value for Asn5 amide proton and from the NOE between the Cys1 and Cys6 alpha-protons. A diminished accessibility of the Asn5 NH proton for the solvent is ascribed to the presence of a beta-turn in the fragment 2-5. The distance between the Cys1 and Cys6 C alpha H protons seems to be less than 4 A. These constraints were taken into account in the conformational analysis of the title peptide. The derived set of the low-energy backbone conformations was analyzed against the background of the all available NMR data. The most probable conformation of the cyclic moiety in des-Gly9-[Arg8]vasopressin was found to be the type III beta-turn. The corner positions are occupied by the residues 3, 4, while the residues 1-2 and 5-6 are at the extended sites. Some NMR data indicate that this structure is in a dynamic equilibrium with other minor conformers.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin

Related Publications

M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
January 1983, Substance and alcohol actions/misuse,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
December 1991, International journal of peptide and protein research,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
July 2000, European journal of biochemistry,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
October 1991, European journal of biochemistry,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
July 1986, European journal of biochemistry,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
April 1986, Bioorganicheskaia khimiia,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
January 1989, Progress in clinical and biological research,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
May 1988, Biochemistry,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
March 1987, Biochemistry,
M D Shenderovich, and I P Sekatsis, and E E Liepin'sh, and G V Nikiforovich, and O S Papsuevich
July 1990, European journal of biochemistry,
Copied contents to your clipboard!